PRESS RELEASE
News
-
-
PRESS RELEASE
Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders
Transgene to participate in upcoming meetings with biotech industry leaders to discuss positive clinical data on neoantigen cancer vaccine TG4050 and present innovative immunotherapies. Learn more at www.transgene.com -
-
-
-
PRESS RELEASE
Adjustment of the Conversion Price for the convertible bond of LEG Immobilien SE in the amount of EUR 400 million due on September 1, 2025 (ISIN DE000A2GSDH2)
LEG Immobilien SE adjusts Conversion Price for EUR 400 million convertible bond due on Sep 1, 2025, following dividend payments. Conversion Price now EUR 112.9577 -
-
-
PRESS RELEASE
Northern Dynasty: Pebble Partnership Consents to EPA Request for Additional 20-day Abeyance to July 3, 2025
Northern Dynasty Minerals Ltd. and its subsidiary Pebble Limited Partnership have agreed to a 20-day abeyance in litigation with the EPA and USACE. The company aims to accelerate copper production in Alaska and the U.S -
PRESS RELEASE
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Moderna receives FDA approval to expand indication of mRESVIA vaccine for adults aged 18-59 at increased risk of RSV, based on Phase 3 study results showing safety and efficacy
